Results 231 to 240 of about 97,240 (266)
Some of the next articles are maybe not open access.
The DNA of murine sarcoma-leukemia virus
Virology, 1971A DNA wih a sedimentation coefficient of 7 S (ρcs2so4: = 1.423) was isolated from DNase- and RNase-treated purified virions of each of three different oncogenic RNA viruses: murine sarcoma virus, Rauscher murine leukemia virus, and avian myeloblastosis virus.
N, Biswal +3 more
openaire +2 more sources
Determinants of Abelson Murine Leukemia Virus Pathogenesis
1986The Abelson murine leukemia virus (A-MuLV) is a rapidly transforming, defective retrovirus that induces pre-B cell tumors in susceptible mice (Abelson and Rabstein 1970, Scher and Siegler 1974, Rosenberg and Baltimore 1976, Risser et al 1978). It encodes the v-abl pl60 transforming protein, a tyrosine-kinase viral oncogene product.
P L, Green +5 more
openaire +2 more sources
Differentiation of abelson murine leukemia virus‐infected promonocytic leukemia cells
International Journal of Cancer, 1985AbstractVirus‐producing, tumorigenic, promonocytic leukemia cell lines were derived from Abelson murine leukemia virus‐infected mice. This study shows that, of these 25 cloned lines, 22 were capable of extensive differentiation. It also shows that granulocyte‐macrophage colony‐stimulating activity increased the proportion of differentiating cells in 17/
openaire +2 more sources
Oncogenesis by Moloney murine leukemia virus.
Anticancer research, 1987Moloney murine leukemia virus (MoMuLV) is a retrovirus which lacks an oncogene. It is, however, highly oncogenic in rats and mice, in whom it induces thymic lymphomas. These lymphomas are clonal tumors and appear four to six months following virus inoculation.
openaire +2 more sources
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Enhancing global access to cancer medicines
Ca-A Cancer Journal for Clinicians, 2020Javier Cortes +2 more
exaly